Jade Biosciences, Inc. (JBIO)

Jade Biosciences Statistics

Total Valuation

JBIO has a market cap or net worth of $276.67 million. The enterprise value is $314.89 million.

Market Cap	276.67M
Enterprise Value	314.89M

Important Dates

The next estimated earnings date is Wednesday, November 5, 2025, before market open.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

JBIO has 32.63 million shares outstanding.

Current Share Class	32.63M
Shares Outstanding	32.63M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+728.11%
Owned by Insiders (%)	1.76%
Owned by Institutions (%)	64.12%
Float	16.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.81

Current Ratio	5.81
Quick Ratio	5.78
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-106.04%
Revenue Per Employee	n/a
Profits Per Employee	-$3.13M
Employee Count	30
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +330.46% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+330.46%
50-Day Moving Average	7.71
200-Day Moving Average	5.55
Relative Strength Index (RSI)	59.31
Average Volume (20 Days)	65,398

Short Selling Information

The latest short interest is 1.74 million, so 5.34% of the outstanding shares have been sold short.

Short Interest	1.74M
Short Previous Month	1.81M
Short % of Shares Out	5.34%
Short % of Float	10.68%
Short Ratio (days to cover)	1.20

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-64.48M
Pretax Income	-93.96M
Net Income	-93.96M
EBITDA	n/a
EBIT	-64.48M
Earnings Per Share (EPS)	-$18.79

Balance Sheet

The company has $69.39 million in cash and $107.60 million in debt, giving a net cash position of -$38.21 million or -$1.17 per share.

Cash & Cash Equivalents	69.39M
Total Debt	107.60M
Net Cash	-38.21M
Net Cash Per Share	-$1.17
Equity (Book Value)	-46.80M
Book Value Per Share	-8.04
Working Capital	57.66M

Cash Flow

Operating Cash Flow	-45.23M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

JBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-33.96%
FCF Yield	n/a

Analyst Forecast

The average price target for JBIO is $16.00, which is 88.68% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.00
Price Target Difference	88.68%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1